Rx IP Update - October 2017

Published date30 October 2017
Law FirmSmart & Biggar
AuthorNancy Pei,Lynn Ing,Kevin Siu,Urszula Wojtyra,Katie Lee,Brandon Heard,Andrew Mandlsohn
Subject MatterPatents,Appeals,Judicial Review,AstraZeneca,Pfizer,Pharmaceutical Patents,CETA,Canada,Competition Authorities,Health Care Providers,Apotex,Supreme Court of Canada,Mandatory Disclosure Rules,Pharmaceutical Industry,Health Canada,Technical Errors,Patented Medicine Prices Review Board (PMPRB)

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT